Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study
Philly O'Riordan, Uli Schwab, Sarah Logan et al. · 2008
Read Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study by Philly O'Riordan, Uli Schwab, Sarah Logan et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003173.txt.
Description
Philly O'Riordan, Uli Schwab, Sarah Logan and colleagues report on fast drug resistance testing for tuberculosis in this 2008 PLOS ONE paper. Multi-drug resistant tuberculosis is a major public health concern because diagnosis is often delayed, raising spread to the community and health workers. Treatment is prolonged, and the total cost of a single case is high. Diagnosis had traditionally been slow.
Their case-control study tests whether rapid molecular detection of rifampicin resistance speeds early diagnosis and treatment of resistant disease. Readers get a practical check on a faster test where time matters. Quicker results can mean earlier correct therapy and less transmission.
Catalog record
| CREATOR | Philly O'Riordan, Uli Schwab, Sarah Logan et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003173